Teknova to Report Second Quarter 2024 Financial Results on August 13, 2024

Rhea-AI Summary

Alpha Teknova (Nasdaq: TKNO), a leading producer of critical reagents for novel therapies, vaccines, and molecular diagnostics, has announced its plans to report second quarter 2024 financial results on August 13, 2024, after market close. The company will host a webcast and conference call on the same day at 5:00 p.m. Eastern Time to discuss the results.

Investors and interested parties can access the live webcast through the Investor Relations section of Teknova's website or via a provided link. To participate in the call, registration is required to receive a unique PIN and dial-in information. A replay of the webcast will be available on the company's website approximately two hours after the event concludes.

HOLLISTER, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2024, on Tuesday, August 13, 2024, following the close of market.

Teknova will host a webcast and conference call on Tuesday, August 13, 2024, beginning at 5:00 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Teknova   
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. Teknova offers fully customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. The Company’s fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps their customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by its team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies.

Investor Contact
Matt Lowell 
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100 

Media Contact
Jennifer Henry
Senior Vice President, Marketing 
jenn.henry@teknova.com
+1 831-313-1259

FAQ

When will Teknova (TKNO) report its Q2 2024 financial results?

Teknova (TKNO) will report its second quarter 2024 financial results on Tuesday, August 13, 2024, after the market closes.

What time is Teknova's (TKNO) Q2 2024 earnings call scheduled for?

Teknova's (TKNO) Q2 2024 earnings call is scheduled for Tuesday, August 13, 2024, at 5:00 p.m. Eastern Time.

How can investors access Teknova's (TKNO) Q2 2024 earnings webcast?

Investors can access Teknova's (TKNO) Q2 2024 earnings webcast through the Investor Relations section of the company's website or by using the link provided in the press release.

Will there be a replay available for Teknova's (TKNO) Q2 2024 earnings call?

Yes, a replay of Teknova's (TKNO) Q2 2024 earnings webcast will be available on the company's website approximately two hours after the event concludes.